BamSEC and AlphaSense Join Forces
Learn More

Travere Therapeutics Inc. – Indentures

NASDAQ: TVTX    
Share price (6/2/26): $42.96    
Market cap (6/2/26): $3.995 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 89 pages Travere Therapeutics, Inc. and U.S. Bank Trust Company, National Association as Trustee First Supplemental Indenture Dated as of May 11, 2026 0.50% Convertible Senior Notes Due 2032 Cross Reference Table*
12/34/56
EX-4.1
from 8-K 59 pages Travere Therapeutics, Inc., as Issuer and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of May 11, 2026 Debt Securities
12/34/56
EX-4.12
from S-3ASR 55 pages Travere Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.11
from S-3ASR 19 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.9
from S-3ASR 20 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3ASR 20 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.1
from 8-K 14 pages Pre-Funded Common Stock Purchase Warrant Travere Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 88 pages Travere Therapeutics, Inc. and U.S. Bank Trust Company, National Association as Trustee Second Supplemental Indenture Dated as of March 11, 2022 2.25% Convertible Senior Notes Due 2029
12/34/56
EX-4.2
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.12
from S-3ASR 55 pages Travere Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Debt Securities
12/34/56
EX-4.11
from S-3ASR 18 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.9
from S-3ASR 20 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3ASR 20 pages Travere Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Travere Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.2
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.2
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.2
from 8-K 83 pages Retrophin, Inc. and U.S. Bank National Association as Trustee First Supplemental Indenture Dated as of September 10, 2018 2.50% Convertible Senior Notes Due 2025
12/34/56
EX-4.1
from 8-K 58 pages Retrophin, Inc., Issuer and U.S. Bank National Association, Trustee Indenture Dated as of September 10, 2018 Debt Securities
12/34/56
EX-4.11
from S-3ASR 55 pages Retrophin, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.10
from S-3ASR 19 pages Retrophin, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Retrophin, Inc. Form of Debt Securities Warrant Agreement Article 1 Issuance of Warrants and Execution And
12/34/56
EX-4.8
from S-3ASR 20 pages Retrophin, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Retrophin, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56